Welcome to PV Reporter

PV Reporter was created to provide “easy access” to pertinent information on Polycythemia Vera (PV),  Essential Thrombocythemia (ET) and Myelofibrosis (MF).  These disorders are Myeloproliferative Neoplasms (MPNs), a closely related group of blood cancers where the bone marrow cells that produce the body’s blood cells function and develop abnormally.

Learn More

Welcome to PV Reporter

PV Reporter is a trusted, patient-founded resource hub for the global myeloproliferative neoplasm (MPN) community, covering polycythemia vera (PV), essential thrombocythemia (ET), and myelofibrosis (MF). Founded by a PV patient in long-term molecular remission, PV Reporter translates the latest MPN research and FDA treatment news into clear, patient-friendly information you can actually use. We feature patient stories from people living with these blood cancers, video interviews with leading MPN specialists from major cancer centers, and plain-language coverage of breakthroughs in JAK2-driven disease, interferon therapy, and emerging clinical research.

PV Reporter is also home to the only doctor-vetted MPN Specialist Directory in the industry, helping patients connect with hematologists who truly understand MPNs, and a free MPN Clinical Trial Finder that requires no personal information so you can explore new treatment options on your own terms. Whether you were newly diagnosed or have lived with an MPN for years, PV Reporter is here to help you become an empowered, informed patient advocate.

error: